Clicky

AbCellera Biologics Inc.(ABCL) News

Date Title
Jul 31 Institutional owners may ignore AbCellera Biologics Inc.'s (NASDAQ:ABCL) recent US$125m market cap decline as longer-term profits stay in the green
Jul 22 Leerink Partners Affirms Outperform Rating on AbCellera Biologics (ABCL) Following Pivot
Jul 22 Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength?
Jul 7 AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025
Jul 7 Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating
Jul 4 Village Farms International And 2 Other Promising Penny Stocks For Your Watchlist
Jun 30 We're Interested To See How AbCellera Biologics (NASDAQ:ABCL) Uses Its Cash Hoard To Grow
Jun 25 AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology
May 10 AbCellera Biologics First Quarter 2025 Earnings: Revenues Disappoint
May 9 AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting
May 9 Q1 2025 Abcellera Biologics Inc Earnings Call
May 9 AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...
May 8 AbCellera Reports Q1 2025 Business Results
Apr 3 AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025
Feb 20 US Penny Stocks To Watch In February 2025
Feb 18 One AbCellera Biologics Insider Raised Their Stake In The Previous Year
Jan 22 3 Promising US Penny Stocks With Market Caps Under $900M
Jan 21 AbCellera to Report Full Year 2024 Financial Results on February 27, 2025
Jan 20 AbCellera Biologics Inc. (NASDAQ:ABCL) most popular amongst individual investors who own 36% of the shares, institutions hold 29%
Jan 17 AbCellera Biologics Inc. (ABCL): A Bull Case Theory